Sample size calculation for bioequivalence studies with high-order crossover designs.
نویسندگان
چکیده
Exact power and sample size calculation for bioequivalence studies with high order crossover designs using statistical software nQuery are presented. Such calculation can be very easily performed, and thus provides a convenient tool for practical usage.
منابع مشابه
On statistical power for average bioequivalence testing under replicated crossover designs.
In its recent guidance on bioequivalence, the U.S. Food and Drug Administration (FDA) recommends a two-sequence, four-period (2 x 4) replicated crossover design be used for assessment of population and individual bioequivalence [FDA. Guidance for Industry on Statistical Approaches to Establishing Bioequivalence; Center for Drug Evaluation and Research, Food and Drug Administration: Rockville, M...
متن کاملSample Size Estimation for (Bio)equivalence Testing Between Two Treatments
Standard 2X2 and replicated 2X2m crossover designs are recommended in the regulatory guidelines to establish bioequivalence of generic drug with off patent brand-name drug. Estimation of sample size, in any clinical trial, targets to optimize the resource usage with assurance of having adequate probability (power) to get significant result. This paper discusses the statistical concept behind sa...
متن کاملSample size estimation in epidemiologic studies
This review basically provided a conceptual framework for sample size calculation in epidemiologic studies with various designs and outcomes. The formula requirement of sample size was drawn based on statistical principles for both descriptive and comparative studies. The required sample size was estimated and presented graphically with different effect sizes and power of statistical test at 95...
متن کاملSample Size Determination for Individual Bioequivalence Inference
Statistical criterion for evaluation of individual bioequivalence (IBE) between generic and innovative products often involves a function of the second moments of normal distributions. Under replicated crossover designs, the aggregate criterion for IBE proposed by the guidance of the U.S. Food and Drug Administration (FDA) contains the squared mean difference, variance of subject-by-formulation...
متن کاملAn Interactive Sas/a~ System for Assessing Bioequivalence
Testing the equivalence of treatments in a two-period crossover design setting occurs often in the pharmaceutical industry. These studies usually compare the rate and extent of absorption of two different drugs or two formulations of the same drug, where one is the accepted standard therapy. The commonly accepted rule for concluding bioequivalence requires the 90% confidence interval for the me...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Controlled clinical trials
دوره 24 4 شماره
صفحات -
تاریخ انتشار 2003